Provider
P23-17 Change to Administration of Interpreter Services for MHCP Subscribers
Program effective Date: May 16, 2017
Documents & Forms Results
ProvidersBulletinsClear All Filters
Displaying 731 - 740 of 1013 results
Provider
P29-17 New Drug-Related Prior Authorization (PA) Criteria: Erythropoietins
Program effective Date: Jun 05, 2017
Provider
P12-17 A New Drug, Pharmaceutical Grade L-Glutamine Will Require Prior Authorization
Program effective Date: Apr 03, 2017
Provider
P28-17 New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Hereditary Angioedema
Program effective Date: May 25, 2017
Provider
P3-17 Added Reimbursement Policies
Program effective Date: Jan 27, 2017
Provider
P15-17 Change to Administration of Interpreter Services for MHCP Subscribers
Program effective Date: Apr 13, 2017
Provider
P34-17 Addition of Drug to the Amitiza (lubiprostone), Linzess (linaclotide), and Trulance (plecanatide) Prior Authorization Program
Program effective Date: Jun 13, 2017
Provider
P27-17 New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Antifungal Agents
Program effective Date: May 25, 2017
Provider
P58-17 New Drug-Related Prior Authorization with Quantity Limit Criteria: Topical Doxepin
Program effective Date: Oct 24, 2017
Provider
P59-16 Organization Determination Additions for Platinum Blue - Effective January 23, 2017
Program effective Date: Dec 08, 2016